rdc-imp

IMPURITY

RD&C developed a novel systemic analysis concept for impurity profiling in pharmaceutical drug process development and impurity related deviation management at development stage or in routine drug manufacturing.

More about impurity

rdc-synergy

SYNERGY

RD&C together with ICIQ develops novel co-crystals and crystalline multi-component structures formed by two or more molecules to generate synergistic efficacy based on improved bioavailability, by increased solubility, or decreased plasma protein binding of current treatment options pursuing the concept of polypharmacology, the treatment of diseases by modulating more than one target.

More about synergy

rdc-concept

CONCEPTS

RD&C combines in depth scientific knowledge of various research disciplines to coordinate and guide innovative concepts for new drug candidates. Regulatory compliant drug development documentation and expert dossiers are provided on sound scientific and regulatory experience.

More about concepts

News

edqm
ema
FDA
AGES
BFarm